By Alius Noreika Key takeaways The question comes up in almost every firm that has started experimenting with

Marcus Mendes:

Apple’s requests to overturn a $634 million patent verdict and secure a new trial in its long-running legal battle with Masimo were denied.

Wesley Hilliard:

There doesn’t appear to be any other path for appeal or recourse, as the judge rejected both requests for either a new judgement or trial.

[…]

In the end, Masimo didn’t succeed in getting the Apple Watch banned or fundamentally redesigned. It won an empty victory with the funds it will be paid, and the patents affecting the lawsuit will expire in 2028 and 2029 anyway.

Paul Terpstra:

Although the ruling confirms the financial penalty, it does not affect current Apple Watch users. The smartwatch’s blood oxygen monitoring feature remains available after Apple introduced a software update in January 2024 that allowed sales to continue despite earlier legal challenges.

Previously:

• Apple Sues OpenAI Over Trade Secrets
• John Ternus Replaces Tim Cook
• Danaher to Buy Masimo
• Apple Loses Blood Oxygen Patent Case
• The Return of Blood Oxygen for Apple Watch
• Apple Watch Sales Paused Over Masimo Patent
• Masimo v. Apple